Trial site
EMC Instytut Medyczny S.A.
- 24running trials
- 10closed trials
The trials here
What the 34 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis12 trials
- Multiple sclerosis6 trials
- Crohn's disease4 trials
- Atopic dermatitis (eczema)3 trials
- Asthma2 trials
- Chronic spontaneous urticaria2 trials
- Psoriasis2 trials
- Chronic kidney disease1 trial
- Heart failure1 trial
- Hidradenitis suppurativa1 trial
- High blood pressure1 trial
- Phase
- Phase 219 trials
- Phase 315 trials
- Status
- Active, not recruiting11 trials
- Recruiting11 trials
- Completed10 trials
- Not yet recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Sanofi4 trials
- AstraZeneca2 trials
- Cinclus Pharma Holding AB2 trials
- Spyre Therapeutics, Inc.2 trials
- and 19 more
Running trials
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis5 recruiting
- Multiple sclerosis3 recruiting
- Asthma1 recruiting
- Chronic kidney disease1 recruiting
- Crohn's disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Psoriasis1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Completed
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026